MacroGenics
MGNX
#9452
Rank
A$0.18 B
Marketcap
A$2.96
Share price
-1.01%
Change (1 day)
34.49%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): A-$0.85

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.86. In 2025 the company made an earnings per share (EPS) of A-$1.78 a decrease over its 2024 EPS that were of A-$1.62.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.85-52.45%
2025A-$1.7810.28%
2024A-$1.62613.33%
2023A-$0.23-92.31%
2022A-$2.95-42.14%
2021A-$5.0936.44%
2020A-$3.73-21.84%
2019A-$4.77-24.58%
2018A-$6.33675.93%
2017A-$0.82-68.05%
2016A-$2.55168.25%
2015A-$0.95-55%
2014A-$2.123400%
2013A-$0.06043-108.68%
2012A$0.7024.49%
2011A$0.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.67-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.26-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.68 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.50-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.83-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.37 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA